Eric Deharo, biologist and pharmacologist at the Institut de Recherche pour le Dveloppement (IRD), working in Bolivia, has just received a special mention from the Altran Foundation (Altran Technologie) jury for his diagnostic kit for Chagas' disease, in the context of the 2002 awards "Technological innovation for the developing countries".
Up to now, in Bolivia imported tests had to be used for detecting Chagas' disease. From now on, they will be produced locally by a Bolivian company, Andilab, set up by means of a partnership between the IRD and the Faculty of Pharmacy of the Universidad Mayor de San Andrs, at La Paz.
Chagas' disease is caused by a flagellate protozoan parasite, Trypanosoma cruzi, transmitted by a blood-sucking louse. Infection hits 24 millions people in the world and about 15% of the Bolivian population are affected by this parasite, although the disease remains in a latent stage for one in two people infected. Existing treatments are effective only in the first phase of the disease, if the tell-tale symptoms are not present (digestive disorders and heart problems). That is why the tests are very important for detecting and treating the disease.
Eric Deharo, is working in partnership with Fernando Vargas, a Bolivian technician. Together they developed a new diagnostic kit, Chagatest, using local strains of the parasite which renders is more effective for Bolivia. It will be produced and marketed, at half the price of imported tests, by Andilab.
'"/>
Contact: Bndicte ROBERT
deval@paris.ird.fr
33-1-48-03-75-19
Institut de Recherche Pour le Dveloppement
8-Jul-2002
Page: 1 Related biology news :1.
Jay Levy honored with 2004 Abbott Laboratories Award in Clinical and Diagnostic Immunology2.
Veterinary College Molecular Diagnostic Labs focus has implications for human health, goal of private development3.
Designer Molecules: Largest Protein Ever Created From Scratch Has Implications For Novel Drug Delivery And Diagnostics4.
Northwestern Researchers Develop Rapid Diagnostic Test To Detect
Antibiotic-Resistant Bacteria5.
Genetic Test For Alzheimers May Improve Diagnostic Reliability6.
New Heart-Attack Indicator Dramatically Improves Diagnostic Accuracy Of ER Doctors: TnT/Echocardiogram Combination Could Reduce Needless Admissions7.
Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases8.
Alzheimers disease is not accelerated aging9.
New molecular link key to cellular proteins involved in cancer progression, other diseases10.
Wildlife Conservation Society hosts public symposium on human-wildlife diseases11.
University of Alberta researcher looks for clues to mysterious disease